Tuesday Mar 11
Genomic Health Inc - 10-K - Management's Discussion and Analysis of...
The following discussion of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the related notes included in Item 8 of this report.
Genomic Health Downgraded by TheStreet to Sell
The analysts wrote, "Genomic Health has been downgraded by TheStreet Ratings from hold to sell.
"Genomic Health, Inc. (GHDX) - Financial and Strategic SWOT Analysis...
Genomic Health, Inc. - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations.
Insider Selling: Kathy L. Hibbs Unloads 1,312 Shares of Genomic Health Stock
Genomic Health SVP Kathy L. Hibbs sold 1,312 shares of Genomic Health stock on the open market in a transaction that occurred on Tuesday, February 18th.
Fluidigm price target raised to $51 from $39 at Piper Jaffray
On The Fly: Analyst Downgrade Summary Today's noteworthy downgrades include: AOL downgraded to Neutral from Buy at BofA/Merrill... Echelon downgraded to Hold from Buy at Needham... Fairway Group downgraded to Hold from Buy at BB&T... Fluidigm downgraded to Market Perform from Outperform at Cowen... Genomic Health downgraded to Neutral from ... (more)